Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Jul;40(1):134-43.
doi: 10.1038/bjc.1979.149.

Peripheral electrophysiological parameters in mice treated with misonidazole

Free PMC article

Peripheral electrophysiological parameters in mice treated with misonidazole

R Von Burg et al. Br J Cancer. 1979 Jul.
Free PMC article

Abstract

The clinical use of the radiosensitizer misonidazole may be limited by the incidence of peripheral neuropathy reported following total doses in excess of 18 g. A recent report noted a decrease in nerve conduction velocity following a single i.p. injection of 1 mg/g misonidazole in mice. The present study was unable to confirm such changes when nerve conduction velocity measurements were made in situ or in isolated sural, tibial or median nerves of mice. Other electrophysiological parameters such as threshold, strength-duration curves, refractory time or the ability to carry high-frequency stimulation also showed no change. However, it was noted that a single administration of the radio-sensitizer produced a marked decrease in body temperature which persisted for at least 2 h after the elimination of the drug from the blood serum. The physiological response of reduction of body temperature may protect the mouse against the effect of the toxic chemical species involved in the induction of neurotoxicity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Physiol. 1956 Mar 28;131(3):678-89 - PubMed
    1. Br J Cancer Suppl. 1978 Jun;3:281-5 - PubMed
    1. Xenobiotica. 1976 AUG;6(8):457-64 - PubMed
    1. Br J Cancer Suppl. 1978 Jun;3:271-5 - PubMed
    1. Br J Cancer Suppl. 1978 Jun;3:268-70 - PubMed